® UPPSALA, SE / ACCESS Newswire / December 17, 2025 / Senzime AB (publ.) (STO:SEZI) (OTCQX:SNZZF) today announced that its Next-generation TetraGraph system has received regulatory clearance for sale in Japan from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). The approval enables further commercialization of Senzimes products in one of the world's largest healthcare markets. In connection with the approval, Senzime received the first order for 80 Next-generation TetraGraph monitors for del ...